Results 61 to 70 of about 19,560 (233)

Adult‐onset Coats disease: A systematic review and meta‐analysis of imaging biomarkers and targeted therapies

Acta Ophthalmologica, EarlyView.
Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco, Nisa Silva, Camiel J. F. Boon   +2 more
wiley   +1 more source

Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti – a case report

BMC Pediatrics, 2019
Background Incontinentia Pigmenti is a rare disease affecting multiple organs. Fifty of patients show affection of the eye with retinopathy and possible amaurosis being the worst outcome.
S. Kunzmann, T. Ngyuen, A. Stahl, J. M. Walz, M. M. Nentwich, C. P. Speer, K. Ruf   +6 more
doaj   +1 more source

Intravitreal Bevacizumab for Traumatic Choroidal Rupture

Optometry and Vision Science, 2015
To report a case of visual loss associated with traumatic choroidal rupture after blunt ocular trauma that was successfully treated with an early intravitreal bevacizumab injection despite the absence of choroidal neovascularization (CNV).A 14-year-old boy presented with visual disturbance in his left eye after sustaining an ocular contusion 4 weeks ...
Min, Kim, Jin Hyung, Kim, Yuri, Seo, Hyoung Jun, Koh, Sung Chul, Lee   +4 more
openaire   +3 more sources

Paradoxical Pyogenic Granuloma Associated With Ramucirumab but Not Bevacizumab: A Case Suggesting Differential Effects of VEGF Receptor and Ligand Inhibition

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We report a case of multifocal pyogenic granuloma that developed during ramucirumab therapy but did not recur after switching to bevacizumab. ABSTRACT Pyogenic granuloma is a benign vascular lesion that may bleed repeatedly and impair daily activities.
Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou   +3 more
wiley   +1 more source

Intravitreal bevacizumab versus ranibizumab: Effects on the vessels of the fellow non-treated eye

Journal of Current Ophthalmology, 2019
Purpose: To evaluate the effects of anti-vascular endothelial growth factors (anti-VEGF) on the vessels of the non-treated eyes following intravitreal injections.
Mohammadreza Peyman, Alireza Peyman, Van C. Lansingh, Amirhossein Orandi, Visvaraja Subrayan   +4 more
doaj   +1 more source

Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study

International Journal of Retina and Vitreous, 2022
Background To investigate the adjunctive effect of an intravitreal ROCK inhibitor (fasudil) in combination with intravitreal bevacizumab (IVB) on refractory macular edema secondary to retinal vein occlusion (RVO).
Sahba Fekri, Ramin Nourinia, Babak Rahimi-Ardabili, Arash Daneshtalab, Hamideh Sabbaghi, Hamid Ahmadieh, Bahareh Kheiri   +6 more
doaj   +1 more source

The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review [PDF]

, 2017
The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor (VEGF) injections on intraocular pressure have not been fully characterized, and the development of sustained ocular hypertension could adversely affect ...
Bracha, Peter, Cantor, Louis B., Ciulla, Thomas A., Moore, Nicholas A., WuDunn, Darrell   +4 more
core   +1 more source

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

Acta Ophthalmologica, Volume 104, Issue 3, Page 296-304, May 2026.
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem, Esra Inci, Martin Breimer, Sofia Töyrä Silfverswärd, Madeleine Zetterberg, Marita Andersson Grönlund   +5 more
wiley   +1 more source

Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation

Clinical Ophthalmology, 2012
Masaaki Saito,1 Tomohiro Iida,1,2 Mariko Kano,1 Kanako Itagaki11Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, 2Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo ...
Saito M, Iida T, Kano M, Itagaki K
doaj  

A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin^® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

Trials, 2008
Background The management of neovascular age-related macular degeneration (nAMD) has been transformed by the introduction of agents delivered by intravitreal injection which block the action of vascular endothelial growth factor-A (anti-VEGF agents). One
Bunce Catey, Patel Praveen J, Tufail Adnan   +2 more
doaj   +1 more source